骨碎补总黄酮的实验及临床研究概况. (Chinese)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Alternate Title:
      Basic and clinical research of total flavonoids from drynaria fortunei. (English)
    • Abstract:
      Total flavonoids from drynaria fortunei,an effective component extracted from drynaria fortunei,have been widely used in basic and clinical research,especially in osteoporosis research. Research at different levels has been conducted to prove the effect of drynaria fortunei flavonoids on osteoporosis,from molecular pathways,such as BMP-smads signal pathway,Wnt /β-catenin pathway,MAPK signal pathway,CTSK signal pathway and OPG /rankl /rank signal pathway,to in vitro cells,bone tissue and clinical research. In addition,the total flavonoids of Rhizoma drynariae can also be used for treating fracture,bone defect,knee osteoarthritis,rheumatoid arthritis,femoral head necrosis,distraction osteogenesis,etc. For the treatment of various orthopedic related diseases,Drynaria fortunei flavonoids can play a role through the same molecular protein pathway. From the microscopic point of view,this reflects the characteristic of traditional Chinese medicine of treating different diseases with the same therapeutic principle. Although drynaria fortunei flavonoids are widely used in basic and clinical fields,further research is needed to explore its mechanism of action,and the interaction between different molecular pathways needs further study and clarification. In addition,the total flavonoids of drynaria fortunei still belongs to mixed ingredients,among which naringin has a prominent function,but it cannot completely replace the function of total flavonoids of drynaria fortune. Therefore it is necessary to further separate and extract it,and identify different effective ingredients that regulate different targets of osteoporosis more accurately. [ABSTRACT FROM AUTHOR]
    • Abstract:
      骨碎补总黄酮作为从中药骨碎补中提取的有效成分,被广泛应用于实验及临床研究。特别是在骨质疏松方面的研究尤 为突出,从分子通路,如 BMP-Smads 信号通路、Wnt /β-catenin 通路、MAPK 信号通路、CTSK 信号通路及OPG/RANKL/RANK 信 号通路等,到体内雌激素水平、体外细胞、骨组织及临床研究等,从不同的层面论证了骨碎补总黄酮抗骨质疏松的作用。骨碎 补总黄酮还可以治疗骨折、骨缺损、膝骨关节炎、类风湿关节炎、股骨头坏死、骨牵张技术等。骨碎补总黄酮在治疗各种不同 骨科疾病时,可通过相同的分子蛋白通路发挥作用,从微观角度体现了中医异病同治的治疗特点。虽然骨碎补总黄酮在基础 研究及临床治疗方面应用广泛,但是其作用机理仍有待探究,不同分子通路之间的相互作用需要进一步明确。另外,骨碎补 总黄酮仍然属于混合成分,其中柚皮苷的作用较为突出,但是并不能完全代替骨碎补总黄酮的作用,需要进一步分离提取,更 精准地找到治疗不同骨科疾病不同靶点的有效成分。 [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Chinese Journal of Osteoporosis is the property of Chinese Journal of Osteoporosis and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)